Telerehabilitation for frail cirrhotic patients awaiting liver transplant: A safe, effective strategy to improve outcomes

Table 1 Sociodemographic and clinical characteristics of the 57 patients included in the telerehabilitation programme

Variable (classes)	n (%)
Male, gender	30 (52.63)
Aetiology of liver disease
Cirrhosis due to alcohol	16 (28.07)
Hepatitis C virus cirrhosis	4 (7.02)
Primary sclerosing cholangitis	2 (3.51)
Late retransplant	10 (17.54)
Autoimmune hepatitis	4 (7.02)
Cryptogenic cirrhosis	7 (12.28)
Metabolic dysfunction-associated steatohepatitis	7 (12.28)
Other	7 (12.28)
Encephalopathy, yes	22 (38.6)
Hepatocellular carcinoma, yes	8 (14.04)
Upper gastrointestinal bleeding, yes	9 (15.79)
Refractory ascites, yes	18 (31.58)
Portal vein thrombosis, yes	3 (5.26)
Outcome
Contraindicated for transplantation/discharge from the transplant program	4 (7.02)
Inactive on the transplant list	1 (1.75)
Active on transplant list	13 (22.81)
Death-before transplantation	6 (10.53)
Transplant performed	33 (57.89)
Group
Non-adherent	40 (70.18)
Adherent	17 (29.82)

The table presents baseline data on sex, aetiology of liver disease, presence of complications, transplant outcomes, and grouping based on programme adherence.